← All companies

JCR Pharmaceuticals Co.,Ltd.

4552 JCRファーマ株式会社
Annual Securities Report Consolidated Current period Pharmaceutical TSE Prime
Revenue
¥40.3bn+21.9% YoY
Operating income
¥555.0mn+108.9% YoY
Net income
¥2.2bn+148.8% YoY
Total assets
¥109.2bn
Compared with
Prior period
Fiscal year covered
2025-04-01 – 2026-03-31
EDINET document
S100YF19

Latest quarter

Q1 cumulative (3 months) · disclosed 30 July 2026 · Consolidated · cumulative from the start of the fiscal year
ItemCumulativeYoY Company forecast (FY)Progress
Revenue¥9.7bn+13.2%¥45.7bn21%
Operating income-¥2.1bn¥1.1bn-191%
Ordinary income-¥2.1bn¥500.0mn-417%
Net income-¥1.9bn¥200.0mn-954%
Progress is the cumulative figure divided by the company's own full-year forecast. Japanese companies publish and revise that forecast every quarter — it is their number, not an analyst estimate.

All reported figures

As filed · extracted from XBRL · no editorial adjustment · hover a row for the XBRL element it came from
ItemJapanesePeriodValue
Revenue売上高Current period¥40.3bn
Revenue売上高Prior period¥33.1bn
Operating income営業利益Current period¥555.0mn
Operating income営業利益Prior period-¥6.2bn
Ordinary income経常利益Current period¥1.2bn
Ordinary income経常利益Prior period-¥7.0bn
Net income attributable to owners of parent親会社株主に帰属する当期純利益Current period¥2.2bn
Net income attributable to owners of parent親会社株主に帰属する当期純利益Prior period-¥4.5bn
Net cash from operating activities営業活動によるキャッシュ・フローCurrent period-¥135.0mn
Net cash from operating activities営業活動によるキャッシュ・フローPrior period-¥5.8bn
Total assets総資産Current period¥109.2bn
Total assets総資産Prior period¥104.8bn
Net assets純資産Current period¥47.4bn
Net assets純資産Prior period¥47.7bn
Cash and cash equivalents現金及び現金同等物Current period¥14.0bn
Cash and cash equivalents現金及び現金同等物Prior period¥13.2bn
Basic EPS1株当たり当期純利益Current period¥17.87
Basic EPS1株当たり当期純利益Prior period¥-36.02
Equity ratio自己資本比率Current period42.9%
Equity ratio自己資本比率Prior period45.1%
Employees従業員数Current period985
Employees従業員数Prior period987
Revenue growth YoY売上高 前年比Current period21.9%
Operating income growth YoY営業利益 前年比Current period108.9%
Net income growth YoY純利益 前年比Current period148.8%
Operating margin営業利益率Current period1.4%
Net margin純利益率Current period5.4%

View the original filing on EDINET →